Literature DB >> 3553439

Serial stereotactic biopsies and CT scan in gliomas: correlative study in 100 astrocytomas, oligo-astrocytomas and oligodendrocytomas.

C Daumas-Duport, V Monsaigneon, S Blond, C Munari, A Musolino, J P Chodkiewicz, O Missir.   

Abstract

Histologic features of 100 supra-tentorial astrocytomas, oligodendrogliomas and oligo-astrocytomas obtained from serial stereotactic biopsies were compared with the corresponding CT scans. Topographic comparisons provided by visualization of the biopsy trajectories on post-biopsy CT scans were available in 24 cases. Areas of contrast enhancement and low attenuation were compared with the histologic grade of malignancy, tumor delimitation and structural type. The latter was determined as follows: Type I-solid tumor tissue without significant peripheral isolated tumor cells; Type II-solid tumor tissue associated with peripheral isolated tumor cells; Type III-isolated tumor cells only. There was a strong correlation between areas of contrast enhancement and tumor microvascularity. In addition, contrast enhancement occurred only in the solid tumor tissue component of the neoplasm. This correlation accounted for the relationship observed between CT images and the structural type of glioma. Contrast enhancement was constant in structural type I gliomas, inconstant in structural type II, and absent in structural type III. No correlation was found between malignancy and contrast enhancement. Contrast enhancement occurred in all grades of malignancy but was a constant feature of grade 4 gliomas. The volume of the tumors could not be reliably determined from CT images alone. Areas of low attenuation on contrast CT scans could correspond to either peritumoral edema or to edematous parenchyma infiltrated by isolated tumor cells. Serial stereotactic biopsies combined with calculations based on the CT scan provided a more precise definition of the tumor volume and identification of structural type. Such classification may prove useful in prospective analysis of various modes of therapy.

Entities:  

Mesh:

Year:  1987        PMID: 3553439     DOI: 10.1007/BF00195602

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  10 in total

1.  An extravascular component of contrast enhancement in cranial computed tomography. Part I. The tissue-blood ratio of contrast enhancement.

Authors:  M H Gado; M E Phelps; R E Coleman
Journal:  Radiology       Date:  1975-12       Impact factor: 11.105

2.  Serial computed tomography of primary brain tumors following surgery, irradiation, and chemotherapy.

Authors:  J E Marks; M Gado
Journal:  Radiology       Date:  1977-10       Impact factor: 11.105

3.  Computed tomography in astrocytomas. A statistical analysis of the parameters of malignancy and the positive contrast-enhanced CT scan.

Authors:  A R Butler; S C Horii; I I Kricheff; M B Shannon; G N Budzilovich
Journal:  Radiology       Date:  1978-11       Impact factor: 11.105

4.  Cerebral gliomas: malignancy, limits and spatial configuration. Comparative data from serial stereotaxic biopsies and computed tomography (a preliminary study based on 50 cases).

Authors:  C Daumas-Duport; J F Meder; V Monsaingeon; O Missir; M L Aubin; G Szikla
Journal:  J Neuroradiol       Date:  1983       Impact factor: 3.447

5.  Effect of dexamethasone treatment on peritumoral brain edema: evaluation by computed tomography.

Authors:  A Hatam; Z Y Yu; M Bergström; B M Berggren; T Greitz
Journal:  J Comput Assist Tomogr       Date:  1982-06       Impact factor: 1.826

6.  Serial stereotactic biopsies: a double histological code of gliomas according to malignancy and 3-D configuration, as an aid to therapeutic decision and assessment of results.

Authors:  C Daumas-Duport; V Monsaingeon; L Szenthe; G Szikla
Journal:  Appl Neurophysiol       Date:  1982

7.  Computerized tomography as a possible aid to histological grading of supratentorial gliomas.

Authors:  S Tchang; G Scotti; K Terbrugge; D Melancon; G Baelanger; C Milner; R Ethier
Journal:  J Neurosurg       Date:  1977-06       Impact factor: 5.115

8.  [Definition of limits and 3D configuration of cerebral gliomas. Histological data, therapeutic incidences (author's transl)].

Authors:  C Daumas-Duport; G Szikla
Journal:  Neurochirurgie       Date:  1981       Impact factor: 1.553

9.  Effect of dexamethasone treatment on volume and contrast enhancement of intracranial neoplasms.

Authors:  A Hatam; M Bergström; Z Y Yu; L Granholm; B M Berggren
Journal:  J Comput Assist Tomogr       Date:  1983-04       Impact factor: 1.826

10.  Effect of large doses of methylprednisolone on supratentorial intracranial tumors. A clinical and CAT scan evaluation.

Authors:  R Leiguarda; J Sierra; C Pardal; D Zambrano
Journal:  Eur Neurol       Date:  1985       Impact factor: 1.710

  10 in total
  13 in total

Review 1.  PCV chemotherapy for oligodendroglioma: response analyzed on T2 weighted-MRI.

Authors:  S Diabira; M C Rousselet; E Gamelin; P Soulier; E Jadaud; P Menei
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

Review 2.  On the principles underlying the diagnosis of brain tumours--a survey article.

Authors:  K G Go; R L Kamman; J Pruim; J M Hew; W Vaalburg; A M Paans; E L Mooyaart; M A Heesters; F H Lopes da Silva
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

3.  Discrimination between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.

Authors:  X Li; D Wang; S Liao; L Guo; X Xiao; X Liu; Y Xu; J Hua; J J Pillai; Y Wu
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-05       Impact factor: 3.825

4.  Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.

Authors:  C Daumas-Duport; M L Tucker; H Kolles; P Cervera; F Beuvon; P Varlet; N Udo; M Koziak; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

5.  Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases.

Authors:  C Daumas-Duport; P Varlet; M L Tucker; F Beuvon; P Cervera; J P Chodkiewicz
Journal:  J Neurooncol       Date:  1997-08       Impact factor: 4.130

6.  Update on central nervous system cytopathology. II. Brain smear technique.

Authors:  J W Ironside
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

7.  Diffuse "fibrillary" astrocytomas: correlation of MRI features with histopathologic parameters and tumor grade.

Authors:  O Tervonen; G Forbes; B W Scheithauer; M J Dietz
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

8.  Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma.

Authors:  M E Berens; G Bjotvedt; D C Levesque; M D Rief; J R Shapiro; S W Coons
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

9.  Use of a neural network and a multiple regression model to predict histologic grade of astrocytoma from MRI appearances.

Authors:  P S Christy; O Tervonen; B W Scheithauer; G S Forbes
Journal:  Neuroradiology       Date:  1995-02       Impact factor: 2.804

10.  CT and MRI aspects of supratentorial hemispheric tumors of childhood and adolescence.

Authors:  F S Finizio
Journal:  Childs Nerv Syst       Date:  1995-10       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.